Diadema Partners »

Compass Pathways shares owned by Diadema Partners

Quarter-by-quarter ownership of Compass Pathways (CMPS) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Compass Pathways

Tip: Access up to 7 years of quarterly data

All positions including Compass Pathways held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Pathways by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $176k 32k 5.53

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Compass Pathways

Deep Track Capital
Rtw Investments
Marshall Wace
Tang Capital Management
Caption Management
BIT Capital GmbH
Susquehanna International
ARK Investment Management
Millennium Management
GMT Capital Corp
Two Sigma Investments
DAFNA Capital Management
Baker Bros. Advisors
Eagle Health Investments
UBS Group

View all funds holding Compass Pathways